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Objectives: Genome-wide association studies have reported that DNA polymorphisms at the CDKN2A locus modulate fasting glucose in human
and contribute to type 2 diabetes (T2D) risk. Yet the causal relationship between this gene and defective energy homeostasis remains elusive.
Here we sought to understand the contribution of Cdkn2a to metabolic homeostasis.
Methods: We ﬁrst analyzed glucose and energy homeostasis from Cdkn2a-deﬁcient mice subjected to normal or high fat diets. Subsequently
Cdkn2a-deﬁcient primary adipose cells and human-induced pluripotent stem differentiated into adipocytes were further characterized for their
capacity to promote browning of adipose tissue. Finally CDKN2A levels were studied in adipocytes from lean and obese patients.
Results: We report that Cdkn2a deﬁciency protects mice against high fat diet-induced obesity, increases energy expenditure and modulates
adaptive thermogenesis, in addition to improving insulin sensitivity. Disruption of Cdkn2a associates with increased expression of brown-like/
beige fat markers in inguinal adipose tissue and enhances respiration in primary adipose cells. Kinase activity proﬁling and RNA-sequencing
analysis of primary adipose cells further demonstrate that Cdkn2a modulates gene networks involved in energy production and lipid meta-
bolism, through the activation of the Protein Kinase A (PKA), PKG, PPARGC1A and PRDM16 signaling pathways, key regulators of adipocyte
beiging. Importantly, CDKN2A expression is increased in adipocytes from obese compared to lean subjects. Moreover silencing CDKN2A
expression during human-induced pluripotent stem cells adipogenic differentiation promoted UCP1 expression.
Conclusion: Our results offer novel insight into brown/beige adipocyte functions, which has recently emerged as an attractive therapeutic
strategy for obesity and T2D. Modulating Cdkn2a-regulated signaling cascades may be of interest for the treatment of metabolic disorders.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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browning1. INTRODUCTION
Obesity is the main risk factor for type 2 diabetes (T2D) and is due to an
imbalance between energy intake and energy expenditure. Current
anti-obesity drugs affecting energy intake or intestinal lipid absorption
cause important and troublesome side effects for the patient, which
limits their use. On the other hand, bariatric surgery has proven efﬁ-
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relapse may arise. Therefore, understanding the signaling pathways
that control fat storage and energy expenditure may open alternative
avenues against obesity and linked T2D.
In animal models, genes such as E2f1 and Sertad2 (TRIP-Br2) have
been shown to prevent fat accumulation and protect against diet-
induced obesity (DIO), but they also improve insulin action in meta-
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Original Articleadipose tissues exist that are anatomically and functionally distinct:
white (WAT) and brown (BAT) adipose tissues. Recent studies have
revealed a new distinct type of thermogenic adipocyte intermingled
within WAT, named beige cells (also known as brite cells). White
adipocytes store excess energy as triacylglycerol and release free fatty
acids (FFAs) as energy substrate when required. On the other hand, the
catabolic capability of BAT and beige adipocytes to burn fat contributes
to reduce circulating FFAs. Indeed, BAT expresses high levels of
uncoupling protein 1 (UCP1), leading to substrate oxidation and sub-
sequent heat production and energy expenditure (for review, see
Ref. [4]). Beige adipocytes also express UCP1 and develop under cold
exposure. This adaptive process is called WAT beiging/browning [5]. In
pathological conditions such as obesity, elevated circulating FFAs are
associated with insulin resistance and T2D. Since energy balance is
modulated by food intake, physical activity, as well as non-shivering
thermogenesis in BAT, increasing energy expenditure by classical
BAT activation or by promoting browning of WAT have recently
emerged as new putative therapy to alleviate the effects of obesity and
prevent insulin resistance and T2D [4,6]. Recent reports in humans
further conﬁrmed the important function of brown/beige adipocytes in
enhancing glucose tolerance and insulin sensitivity [7,8]. Therefore,
the identiﬁcation of selective molecular pathways for beige adipocyte
biogenesis would represent a ﬁrst step towards innovative therapeutic
options.
Genome-wide association studies (GWASs) have established the
CDKN2A/B locus as a hotspot inﬂuencing genetic risk for different
cardio-metabolic diseases including T2D [9,10]. CDKN2A/B single
nucleotide polymorphisms associated with T2D also modulate fasting
insulin and insulin sensitivity in non-diabetic subjects [11]. In partic-
ular, rs10757278-G and rs10811661-T SNPs are situated near the
CDKN2A/B locus on chromosome 9p21.3 and are respectively asso-
ciated with the risk for coronary artery disease (CAD) and T2D [12].
The genomic regions containing those SNPs are also in close vicinity of
the long non-coding RNA ANRIL (Antisense Non-coding RNA in the
Inhibitor of CDK4 (INK4) Locus). The function of ANRIL is still unknown
but it seems to be involved in the epigenetic repression of the
CDKN2A/B locus [13]. Although rs10757278 and rs10811661 are less
than 10 kb away from CDKN2A/B genes, those SNPs may affect dy-
namic chromosome structures and genome activity. Indeed,
rs10811661 is negatively associated with a trans-eQTL, presenilin 1
(PSEN1), a gene associated in mice with glucose intolerance and in-
sulin resistance [14]. In addition, Lillycrop et al. recently demonstrated
that decreased DNA methylation at the CDKN2A gene is associated
with a higher risk for a child to develop obesity during adulthood [15].
Furthermore, rare heterozygous loss-of-function mutations in CDKN2A
affect glucose homeostasis through its metabolic role in pancreatic
beta cells and liver [16]. Altogether, those results pinpoint the
importance of studying the impact of loss-of-function of CDKN2A in
metabolic tissues.
The human CDKN2A locus encodes for p16INK4a a CDK inhibitory (CDKI)
protein and the p53 regulatory protein p14ARF (p19ARF in mice),
whereas the CDKN2B gene encodes another CDKI, p15INK4b. Products
of the CDKN2A/B locus are involved in apoptosis, senescence, and
aging [9]. Whilst p16 and p15 are potent CDKI preventing binding of
CDK4/6 to Cyclin D, p14ARF mainly exerts it anti-proliferative activity via
the inhibition of MDM2, an ubiquitin-ligase that modulates the activity
of the tumor suppressor p53. The CDKN2A/B pathway is involved in
metabolic control through several ways including adipocyte differen-
tiation [17e19], macrophage polarization [20], fastedefed transition
[21,22], muscle metabolism [1], and pancreatic beta cell proliferation,
regeneration, and function [23e25].66 MOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. ThWhile rodent and human studies have highlighted the potential role of
CDKN2A on insulin secretion [16,26], the contribution of CDKN2A to
the control of insulin sensitivity is still elusive.
To decipher the link between Cdkn2a, obesity and insulin resistance,
we analyzed the effect of Cdkn2a deﬁciency in mice on metabolic
homeostasis [27]. Here, we demonstrate that the genetic deletion of
Cdkn2a promotes energy expenditure and improves insulin sensitivity
during DIO. We found that the Cdkn2a locus modulates signaling
pathways in inguinal WAT (ingWAT), where it controls beige adipocyte
development. Importantly, we observed that CDKN2A expression is
increased in adipocytes from obese patients. CDKN2A silencing during
human-induced pluripotent stem cells adipogenic differentiation pro-
moted UCP1 expression. These data suggest that Cdkn2a plays a key
role in energy metabolism by regulating a white-to-brown fat
transition.
2. MATERIAL AND METHODS
2.1. Materials and oligonucleotides
Chemicals, unless stated otherwise, were purchased from Sigmae
Aldrich. Anti-UCP1 antibody was purchased from Abcam, and anti-PKA
substrate antibody was from Cell Signaling Technology. The oligonu-
cleotides sequences used for various experiments are listed in
Table S5.
2.2. Animals experiments
Cdkn2aþ/þ and Cdkn2a/ mice were previously described [27]
and were maintained on a mixed background according to Euro-
pean Union guidelines for use of laboratory animals. In vivo experi-
ments were performed in compliance with the French ethical
guidelines for studies on experimental animal (Animal house agree-
ment no. B 59-35015, Authorization for Animal Experimentation no.
59-350294, project approval by our local ethical committee no. CEEA
482012). All experiments were performed with healthy male mice.
Animals with detectable tumors were excluded from the study. Mice
were housed under a 12 h lightedark cycle and given a regular chow
(A04; Safe). For HFD studies, 8-week old mice were placed on
D12492 diet (60% cal/fat; Research Diet Inc.) for 13 weeks. Metabolic
phenotyping experiments were performed according to the EMPRESS
protocols (http://empress.har.mrc.ac.uk). Brieﬂy, intraperitoneal
glucose (2 g of glucose per kg of body weight) and insulin (0.75 U of
insulin per kg of body weight) tolerance tests were performed as
previously described [28,29] on 16-h-fasted animals for IPGTT and 5-
h-fasted animals for ITT. Glycemia was measured before and at
different time after glucose and insulin injections using the Accu-
Check Performa (Roche Diagnostics). Circulating insulin levels were
measured using the Ultrasensitive Insulin Elisa kit (Mercodia). For cold
experiments, mice were maintained at þ23 C or placed at þ4 C for
5h and fasted during the time of the experiment. Body temperature
was measured using a rectal probe as described previously [1].
Metabolic rate was measured by indirect calorimetry using the Phe-
nomaster metabolic cage system (TSE Systems). Mice were housed
individually and maintained at 23 C under a 12 h light/12 h dark
cycle. Food and water were available ad libitum. Mice were sacriﬁced
by cervical dislocation and tissues were harvested and snap-frozen for
further processing.
2.3. RNA extraction, measurements, and proﬁling
Total RNA was extracted from rodent cells and tissues using trizol
reagent (Life Technologies) as described previously [1,28]. mRNA
expression was measured after reverse transcription by quantitativeis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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real-time PCR (qRT-PCR) with FastStart SYBR Green master mix
(Roche) according to the manufacturer’s recommendations and gene-
speciﬁc oligonucleotides. Mouse qRT-PCR results were normalized to
endogenous cyclophilin reference mRNA levels. The results are
expressed as the relative mRNA level of a speciﬁc gene expression
using the formula 2DCt. For human cells, RNAs were puriﬁed on
RNeasy Plus Universal columns (Qiagen, France) according to the
manufacturer’s instructions. Total RNA sample concentrations were
determined using a Nanodrop spectrophotometer (Thermo Scientiﬁc,
Waltham, MA, USA). 1 mg RNA was used for reverse transcription.
Real-time PCR assays were run on a OneStep real-time PCR machine
(Applied Life Sciences) and SYBR green was from Applied Biosystems.
Normalization was performed using the geometric averages of the
housekeeping gene TBP. Delta Ct values were used to achieve relative
quantiﬁcation of gene expression when “expression relative to TBP” is
indicated.
2.4. Histology, immunoﬂuorescence (IF), and
immunohistochemistry (IHC)
IF and IHC were performed exactly as described previously [1,28].
Brieﬂy, deparafﬁnized adipose tissues sections (5 mm) were subjected
to heat-induced antigen retrieval. The slides were incubated with 0.3%
H2O2 for 10 min to quench the endogenous peroxidase. The sections
were then incubated in 1% BSA/PBS for 10 min, followed by overnight
incubation with primary (Rabbit-UCP1) antibodies at 4 C. Afterward,
the slides were incubated at room temperature for 2 h with horseradish
peroxidase (HRP)-conjugated (for IHC) or Alexa-conjugated anti-rabbit
secondary antibodies (for IF, Fischer Scientiﬁc). The IHC staining was
developed using fast 3,30-diaminobenzidine (DAB) tablet sets (D4293;
Sigma, St. Louis, MO, USA). The sections were counterstained with
hematoxylin and examined by light microscopy. H&E staining was
performed using classical protocols. For IF, nuclei were stained with
Hoechst. Images were processed using ImageJ software by two ob-
servers blinded to experimental groups.
2.5. Protein extracts, PKA activity measurement and immunoblot
analysis
Immunoblot was performed as described previously [1,29]. Tissues
and cells were washed using cold PBS, and lysis was performed by
using 50 mM TriseHCl pH 8, 137 mM NaCl, 10% glycerol, 1% NP-40
and phosphatase, protease, deacetylase inhibitors (SigmaeAldrich)
on ice. Western blotting was performed using 30 mg of proteins
loaded on SDS-PAGE precast gel (Biorad). After electrotransfer, the
membrane was blocked for 1 h at room temperature with 5% nonfat
milk in 0.1% TweeneTris-buffered saline (TTBS) buffer. Membranes
were then incubated overnight at 4 C with primary antibodies as
indicated in blocking buffer containing 5% nonfat milk or 0.5% bovine
serum albumin at the dilution speciﬁed by the manufacturers. Sub-
sequently, membranes were incubated with the secondary antibody
conjugated with the horseradish peroxidase enzyme. The visualization
of immunoreactive bands was performed using the enhanced
chemiluminescence plus western blotting detection system (GE
Healthcare). hiPSCs-BAP cells were rinsed with PBS and solubilized in
stop buffer containing 50 mM Hepes, pH 7.2, 150 mM NaCl, 10 mM
EDTA, 10 mM Na4P2O7, 2 mM Na3VO4, and 1% Triton X-100 sup-
plemented with Protease Inhibitor Cocktail (Roche). The primary an-
tibodies and dilutions used were: UCP1 (1/500, Abcam), Tubulin (1/
10,000, Sigma); secondary horseradish peroxidase-conjugated anti-
bodies were purchased from Sigma. Quantitation of protein signal
intensity was performed by volume densitometry using the ImageJ
1.47t software (National Institutes of Health). PKA activity wasMOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.commeasured on tissue homogenates using the non-radioactive PKA
Kinase Activity assay kit following manufacturers’ instructions
(Abcam).
2.6. Primary adipocyte cell culture
The stromal vascular fraction (SVF) of inguinal adipose or BAT tissues
of 8-week old mice was isolated by collagenase (ROCHE) digestion
followed by two alternative ﬁltration steps (using 100 and 40 mM
strainers) and centrifugations for 5 min at 700  rpm. Cells were then
plated and differentiated upon conﬂuence in DMEM/F-12 GlutaMAX
with adipogenic cocktail (0.5 mM 3-isobutyl-1-methylxanthine [IBMX],
2.5 mM dexamethasone, 1 mM rosiglitazone, 0.02 mM insulin for
inguinal cells and 0.02 mM insulin, 0.125 mM indomethacin, 0.5 mM 3-
isobutyl-1-methylxanthine [IBMX], 2.5 mM dexamethasone and 1 nM
T3, for BAT cells) for 48 h. Inguinal cells were maintained in 0.02 mM
insulin and BAT cells in 1 nM T3 and 0.02 mM insulin. Cells were
harvested at days 8 post-differentiation. To label lipid droplets, fully
differentiated primary adipocytes cells were ﬁxed in 4% PFA then
labeled with BODIPY 493/503 lipid probe solution (Molecular Probes/
Life Technologies) for 30 min. After PBS wash the staining was
examined by ﬂuorescence microscopy.
2.7. Cell culture and siRNA experiments
Brown-like adipose progenitors (BAPs) were derived from human-
induced pluripotent stem cells (hiPSCs) and induced to undergo
adipocyte differentiation as described in Mohsen-Kanson et al. [65]
and Hafner et al. [66]. For more details see http://www.nature.com/
protocolexchange/protocols/5175. hiPSC-BAPs were transfected with
small interfering RNA duplexes (Human CDKN2A siRNA-SMART pool,
GEHealth Bio-Sciences, Rosersberg, Sweden) using HIPerfect reagent
(Qiagen, France) during the exponential growth phase as described by
the supplier.
2.8. Pamgene experiments
For kinome analysis, STK microarrays were purchased from PamGene
International BV (STK pamchips, Ref. [32]). Each array contained 140
phosphorylatable peptides as well as 4 control peptides. Sample
incubation, detection, and analysis were performed in a PamStation
12 according to the manufacturer’s instructions. Brieﬂy, extracts from
fully differentiated day 8 (D8) primary adipocytes from Cdkn2aþ/þ
and Cdkn2a/ mice were freshly prepared using M-PER
mammalian extraction buffer (Thermo Scientiﬁc) containing 1:50 Halt
phosphatase inhibitor cocktail (Thermo Scientiﬁc) and 1:50 Halt
protease inhibitor cocktail, EDTA-free (Thermo Scientiﬁc) for 20 min
on ice. The lysates were then centrifuged at 15,871 g for 20 min to
remove all debris. The supernatant was aliquoted, snap-frozen in
liquid nitrogen, and stored at 80 C until further processing. Prior to
incubation with the kinase reaction mix, the arrays were blocked with
2% BSA in water for 30 cycles and washed 3 times with the PK assay
buffer. Kinase reactions were performed for 1 h with 2.5 mg of total
extract of the mature adipocyte and 400 mM ATP at 30 C. Phos-
phorylated peptides were detected with an anti-rabbit-FITC antibody
that recognizes a pool of anti-phospho serine/threonine antibodies.
The instrument contains a 12-bit CCD camera suitable for imaging of
FITC-labeled arrays. The images obtained from the phosphorylated
arrays were quantiﬁed using the BioNavigator software (PamGene
International BV), and the list of peptides whose phosphorylation was
signiﬁcantly different between Cdkn2aþ/þ and Cdkn2a/ was
uploaded to IPA for pathway analysis. The BioNavigator software was
used to perform the HPRD based upstream kinase determination that
is shown in Figure 4C.n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 67
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Total RNA was extracted from primary adipocytes 8 days after dif-
ferentiation using the RNeasy Microkit (Qiagen) following manufac-
turer’s instructions. RNA quality was veriﬁed using RNA 6000
nanochips on the Agilent 2100 bioanalyzer. Puriﬁed RNA (200 ng) with
RNA integrity number 8 was subsequently used for library prepa-
ration (TruSeq Stranded mRNA Library Preparation Kit, Illumina) and
sequenced on a HiSeq2500 (Illumina). Three biological replicates per
condition were sequenced in paired-end. A mean of 54 million paired-
end reads of 75 bp were generated for each sample. After initial
checks and validation of sequence quality, RNA-seq reads were
aligned to the mouse reference genomes (mm10) using TopHat2 [33].
Subsequently, both quantiﬁcation and annotation of the reads were
performed using Bioconductor package Rsubread [34]. Finally, the
differential gene expression analyses were performed using Bio-
conductor package DESeq2 [35]. Using a p < 0.05 adjusted for
multiple comparisons as threshold, we then performed pathway
analysis using Ingenuity Pathway Analysis (Ingenuity Sytems).
2.10. Seahorse experiments
Oxygen consumption rate (OCR) was performed using the XF24e plat-
form from Seahorse Biosciences. Primary adipocytes from Cdkn2aþ/þ
and Cdkn2a/ mice were grown and differentiated in a Seahorse
plate. Growth medium was replaced with 37 C seahorse DMEM 1 h
before the measurement to allow equilibrium. Measurement was per-
formed at 37 C, using 3e3e3-min intervals. Basal respiration was
measured then uncoupled, and maximal OCR were determined using
oligomycin and carbonyl cyanide p-triﬂuoromethoxyphenylhydrazone
(FCCP, 1 mM each), respectively. Complex I-dependent respiration was
inhibited with rotenone (3 mM). OCR data were normalized using total
protein or DNA content as indicated.
2.11. Human adipocyte expression data
Gene Expression Omnibus (GEO) analysis from the NCBI was per-
formed using “adipocytes obese human” as keywords, ﬁltered with
“published in the last year” and sorted by the number of samples “high
to low”. The dataset GSE94753 [36] was selected and analyzed using
GEO2R. The platform GPL11532 was selected and groups were
deﬁned using the disease status (lean, WAT, control versus obese
resistant, WAT OIR). Expression level data were extracted from “proﬁle
graph” using CDKN2A ID 8160441.
2.12. Statistical analysis
Data are presented as mean  SEM. Statistical analyses were per-
formed using unpaired two-tailed Student’s t-test, one-way ANOVA
with least signiﬁcant difference Bonferroni post hoc test or two-way
ANOVA with Bonferroni post hoc tests as appropriate using Graph-
Pad Prism software. Differences were considered statistically signiﬁ-
cant at p < 0.05 (*p < 0.05; **p < 0.01 and ***p < 0.001).
3. RESULTS
3.1. Germline Cdkn2a deﬁciency improves insulin sensitivity in
mice
We ﬁrst analyzed the metabolic proﬁle of Cdkn2a-deﬁcient mice [27].
9- to 12-week old Cdkn2aþ/þ and Cdkn2a/ mice fed a chow diet
(CD) displayed similar body weight (Figure 1A), glucose tolerance
(Figure 1B, C) and fasting glycemia (Figure S1A). In vivo glucose
stimulated insulin secretion (GSIS) was similar in both genotypes under
CD (Figure 1D). After 13 weeks of high fat diet (HFD) feeding, body
weight of Cdkn2a/ mice was lower than that of age-matched68 MOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. Thcontrol mice (Figure 1E), with comparable fasting glucose levels
(Figure S1B) and similar glucose clearance during ipGTT tests
(Figure 1F, G). As expected, upon HFD feeding Cdkn2aþ/þ had
increased basal insulin secretion to maintain normal glucose levels,
indicating an insulin-resistant state (Figure 1H). By contrast, HFD
Cdkn2a-deﬁcient mice displayed lower basal insulin levels and were
still responsive to a glucose load (Figure 1H), suggesting that Cdkn2a
deﬁciency may affect insulin sensitivity rather than insulin production
by the pancreatic beta cells. Consistently, insulin sensitivity was
signiﬁcantly improved in Cdkn2a/ mice under CD (Figure 1I, J) and
even more under HFD (Figure 1K, L). These results indicate that
Cdkn2a deﬁciency prevents weight gain and improves insulin sensi-
tivity during metabolic stress.
3.2. Increased energy expenditure in Cdkn2a/ mice
To characterize the effect of Cdkn2a deﬁciency on insulin sensitivity
and body weight, we monitored energy expenditure using indirect
calorimetry measurements. Under CD, Cdkn2a/ mice showed
increased food intake only during the second (1AM to 7AM) part of the
dark phase compared to controls (Figure 2A and Figure S2A), but this
was doubled under HFD during the entire dark phase (Figure 2B and
Figure S2B). The reduced body weight gain under HFD (Figure 1)
despite an increase in food intake suggests enhanced energy expen-
diture. The ambulatory activity was similar among all genotypes either
under CD (Figure S2C, D) or HFD (Figure S2E, F). Interestingly,
Cdkn2a/ mice showed increased energy expenditure measured by
heat production, under both CD (Figure 2C and Figure S2G) and HFD
(Figure 2D and Figure S2H). This increased metabolic rate was not due
to substrate utilization preference (glucose or free fatty acids), since no
signiﬁcant difference in respiratory exchange ratio (RER) was observed
between Cdkn2aþ/þ and Cdkn2a/ mice (Figure 2E, F and
Figure S2I, J). We then investigated adaptive thermogenesis by either
performing a cold test or subjecting mice to 6 h of fasting. During an
acute cold stress or under fasting conditions Cdkn2a/ mice
maintained a higher body temperature as compared to control animals
(Figure 2G, H). Altogether, these ﬁndings suggest that the global ge-
netic deletion of Cdkn2a locus in mice enhances energy expenditure
and adaptive thermogenesis.
3.3. Beige fat programming is dependent on Cdkn2a
To determine if Cdkn2a regulates brown and beige adipocyte function,
we ﬁrst analyzed BAT thermogenic gene expression in Cdkn2aþ/þ
and Cdkn2a/ mice. Ucp1 and Prdm16 expression increased in
Cdkn2a-deﬁcient BAT fed a CD or HFD (Figure 3A, B). Ppargc1a
expression was similar in control and Cdkn2a-deﬁcient BAT under CD,
but raised upon HFD in Cdkn2a/ BAT (Figure 3A, B). Mitochondrial
content (Figure S3A) and Ucp1 protein levels (Figure S3B, C) were
identical in Cdkn2aþ/þ and Cdkn2a/ BAT tissue homogenates.
Total BAT mass was not signiﬁcantly different in Cdkn2aþ/þ and
Cdkn2a/ mice fed CD, but was decreased in HFD-fed Cdkn2a/
mice (Figure S3D, E). When expressed relative to total body weight no
difference between genotypes was observed (Figure S3F, G), sug-
gesting that Cdkn2a deﬁciency may have a week effect on BAT
functions. When measuring p16, p19, and Ucp1 mRNA levels in
different mouse fat depots, we observed that p16 (Figure 3C) and p19
(Figure 3D) were mostly expressed in inguinal WAT (ingWAT)
compared to epididymal WAT or BAT, whereas Ucp1 (Figure 3D) was
strongly expressed in BAT depots. We then hypothesized that the
Cdkn2a gene products p16 and p19 may promote the WAT beiging/
browning process. To determine if Cdkn2a deﬁciency modiﬁes beige
adipocyte differentiation, we compared the expression levels of severalis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Cdkn2a-deﬁcient mice are insulin sensitive during DIO. (A) Body weight of 9- to 12-week old control (Cdkn2aþ/þ) and mutant (Cdkn2a/) mice fed with chow
diet (CD, n ¼ 30e32). (B, C) Intraperitoneal glucose tolerance test (ipGTT, B) in Cdkn2aþ/þ and Cdkn2a/ mice fed with CD (n ¼ 11e12) and the corresponding area under the
curve (AUC, C) of ipGTT. (D) Blood insulin levels as measured during ipGTT in CD-fed mice. (E) Body weight of high fat diet (HFD, n ¼ 7e16) fed mice. (F, G) ipGTT in HFD mice (F,
n ¼ 7) and its AUC (G). (H) Blood insulin levels during ipGTT in HFD-fed mice. (I) Intraperitoneal insulin tolerance test (ipITT) in 8 weeks mice fed with CD (n ¼ 7). (J) AUC of ipITT.
(K, L) ipITT in HFD-fed mice (K, n ¼ 7) and the corresponding AUC of ipITT (L). All values are expressed as means  SEM; *p < 0.05, **p < 0.01, and ***p < 0.001.adipocyte markers between control and Cdkn2a-deﬁcient animal’s
ingWAT. The expression of brown fat-selective genes Ppargc1a, Ucp1,
Prdm16, Tfam, Cox5a, Cox8a, and Dio2 was increased in ingWAT from
CD-fed Cdkn2a/ animals (Figure 3F). This effect was more pro-
nounced in HFD-Cdkn2a/ ingWAT (Figure 3G). Hematoxylin and
eosin (H&E) staining showed that Cdkn2a/ ingWAT had smaller
adipocytes with multilocular lipid droplets (Figure 3H), associated with
an increase in UCP1 immunostaining (Figure 3H), further conﬁrmed
through immunoblot (Figure 3I, J) and immunoﬂuorescence
(Figure S3H) experiments. Mitochondrial content was identical in
Cdkn2aþ/þ and Cdkn2a/ ingWAT (Figure S3A). Altogether, these
data suggest that Cdkn2a deﬁciency induces a white-to-brown fat
conversion in ingWAT.
3.4. The effect of Cdkn2a on browning is cell-autonomous and
requires the activation of the Protein Kinase A pathway
Stromal vascular cells from ingWAT and BAT can be differentiated into
brown-like adipocytes. To determine the cell-autonomous requirement
of Cdkn2a to the beiging process, we isolated ingWAT and BAT pre-
adipocytes from control and Cdkn2a-deﬁcient mice and differenti-
ated them for 8 days (Figure S4A). Lipid droplet accumulation was
more pronounced in Cdkn2a/ ingWAT and BAT differentiated pri-
mary adipocytes, but not in adipocytes differentiated from epididymal
pre-adipocytes (eWAT, Figure S4B). We next examined the expression
of adipocytes (Fabp4) and brown/beige fat markers (Ppargc1a, Ucp1,MOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comPrdm16, Cox5a, Cidea, Elovl3, Dio2) and observed a strong induction
of these genes in differentiated ingWAT primary cells upon p16 and
p19 genetic deletion (Figure 4A), but not in differentiated BAT or eWAT
primary cells (Figure S4C and data not shown).
The Cdkn2a products p16ink4a and p19ARF are key regulators of the
activity of serine/threonine kinases (STK) involved in cell proliferation
and senescence [9]. We postulated that STK may be involved in beige
fat programming and performed a global kinome analysis in primary
Cdkn2aþ/þ and Cdkn2a/ differentiated adipocytes. We used
Pamgene arrays containing 140 serine/threonine peptides that are the
substrates of one or multiple kinases. We incubated these chips with
protein lysates of primary adipocytes after 8 days of differentiation
(D8). We then analyzed the phosphorylation status of these peptides
and identiﬁed the putative upstream kinases involved. At D8, 47
peptides with signiﬁcant differences in phosphorylation levels between
control and Cdkn2a-deﬁcient adipocytes were observed (Figure 4B and
Table S1). Using the Human Protein Reference Database (HPRD) [37] to
identify potential upstream kinases we identiﬁed several signaling
pathways that may be affected in Cdkn2a-deﬁcient adipocytes,
including Protein Kinase A (PKA) and Protein Kinase G (PKG) signaling
pathways. Interestingly, PKG is an important regulator of WAT
browning [38,39]. For some phosphorylated peptides upstream ki-
nases could not be identiﬁed using HPRD analysis (Figure 4B, NA or e
). When we analyzed the diseases and/or biological functions affected
by the differences in peptide phosphorylation observed upon Cdkn2an access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 69
Figure 2: Increased energy expenditure in Cdkn2a/ mice. (A, B) Cumulative food intake in (A) CD and (B) HFD-fed control (Cdkn2aþ/þ) and mutant (Cdkn2a/) mice
(n ¼ 4) measured during the dark (7PM to 1AM and 1AM to 7AM) and the light (7AM to 1PM and 1PM to 7PM) periods. (C, D) Heat production in (C) chow diet and (D) HFD-fed
mice. (E, F) Respiratory exchange ratio (RER) in (E) CD and (F) HFD-fed mice. (G, H) Body temperature in CD-fed Cdkn2aþ/þ and Cdkn2a/ mice after 5 h fasting (G, n ¼ 4) and
5 h of cold exposure (H, n ¼ 4). All values are expressed as means  SEM; *p < 0.05, **p < 0.01, and ***p < 0.001.
Original Articlegenetic deﬁciency through Ingenuity Pathway Analysis (IPA), we found
networks related to “Cancer,” “Organismal Injury and Abnormalities,”
and “Developmental Disorders,” but also to “Cardiovascular Disease”
(Table S2). Then we found a signiﬁcant enrichment of potential
signaling pathways upstream kinases involved in “Protein Kinase A
Signaling” in Cdkn2a-deﬁcient cells (P ¼ 1.07  1015; Figure 4C),
conﬁrming HPRD analysis. In addition, “AMPK signaling”
(P ¼ 4.96  1012; Figure 4C), “synaptic long-term potentiation”
(P ¼ 1.28  1010; Figure 4C), “prostate cancer signaling”
(P ¼ 9.26  1010; Figure 4C) or “Molecular Mechanisms of Cancer”
(P ¼ 3.92  1009; Figure 4C) were canonical pathways also affected
in Cdkn2a/ primary adipocytes. These analyses prompted us to
focus on dissecting the contribution of PKA to our phenotype. Increased
PKA activity was conﬁrmed in Cdkn2a/ ingWAT homogenates,
whereas no changes were found in BAT or eWAT (Figure 4D and data
not shown). The increased PKA activity was further conﬁrmed in
Cdkn2a/ ingWAT using protein homogenates and an anti-PKA
phospho-substrate antibody (Figure S4D, E). The increase in PKA ac-
tivity was associated with a signiﬁcant raise in basal and maximal
respiration, as well as basal proton leak of Cdkn2a/ primary
ingWAT cells, as measured by oxygen consumption rate (OCR,
Figure 4E, F). The PKA inhibitor H89 completely abolished PKA activity
in tissue homogenates (Figure 4D) as well as the increase of oxygen
consumption observed in Cdkn2a/ primary cells (Figure 4E, F).
Altogether, these ﬁndings indicate that Cdkn2a modulates PKA activity
in adipocytes, oxygen consumption and promotes beiging in ingWAT.
Our results also suggest that Cdkn2a may regulate other pathways,
such as PKG, that can further contribute to adipose beiging.
3.5. Cdkn2a modulates a regulatory gene network involved in
brown adipocyte function
We next carried out RNA-sequencing (RNA-seq) analysis in Cdkn2aþ/
þ and Cdkn2a/ primary adipocytes at D8 of differentiation. We70 MOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. Thfound 11,855 transcripts differentially expressed (Table S3). IPA
highlighted the presence of a network of 98 genes associated to
Cdkn2a deletion which was involved in “energy production, lipid
metabolism and small molecule biochemistry,” including Ppargc1a
and Prdm16 (Figure S5A). Subsequently, we analyzed the diseases
and/or functions associated to Cdkn2a deﬁciency. The main differ-
ences between Cdkn2aþ/þ and Cdkn2a/ primary adipocytes
were included into “carbohydrate metabolism” (P ¼ 1.67  103) or
“cellular development, connective tissue development and function,
tissues development” (P ¼ 4.36  103; Table S4). Next, we used
the “upstream regulator analysis” function of IPA to identify potential
contributors to the phenotype of Cdkn2aþ/þ and Cdkn2a/ pri-
mary adipocytes. Among the most signiﬁcant upstream regulators,
tumor necrosis factor (TNF) and promyelocytic leukemia (PML)
signaling pathways were activated (Table 1). Interestingly, norepi-
nephrine, which acts on b-AR receptors in BAT [40] and WAT [41,42],
was also activated (Table 1). This analysis further revealed a potential
inhibition of the NR1H2 pathway, which has been associated to severe
obesity [43] (Table 1). Transcription factor network analyses revealed
that PPARGC1A and PRDM16 were activated in Cdkn2a/ cells
(Table 2). The period circadian clock 2 (PER2) transcription factor was
also activated (Table 2). This is consistent with the observation that
PER2 is necessary for adaptation to cold temperature in mice through
the regulation of Ucp1 expression [44]. Moreover, Aryl hydrocarbon
receptor nuclear translocator like (ARNTL) activity is potentially
inhibited in our model (Table 2), in agreement with its antagonistic role
on PER2 in the control of the circadian rhythm. Finally, the marked
inhibition of inhibitor of DNA (ID1) further conﬁrmed the brown-like
features of Cdkn2a/ primary adipocytes. Indeed, germline deﬁ-
cient Id1 mice are protected against DIO through enhanced energy
expenditure [45]. These RNA-seq data further suggest that Cdkn2a is
a crucial regulator of effectors controlling the expression of brown-like
markers.is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Cdkn2a deﬁciency promotes the browning process in vivo. (A, B) mRNA level of thermogenic genes in BAT from Cdkn2aþ/þ and Cdkn2a/ mice fed chow (A) or
HFD (B, n ¼ 5e6). (CeE) mRNA levels of p16 (C), p19 (D) and Ucp1 (E) in epididymal WAT (epiWAT), inguinal WAT (ingWAT) and BAT. (F, G) mRNA levels for adipogenic and
thermogenic genes in ingWAT from Cdkn2aþ/þ and Cdkn2a/ mice fed CD (F) or HFD (G, n ¼ 5e6). An inset of some genes is represented. (H) Hematoxylin and eosin (H&E)
staining and UCP1 immunohistochemistry of representative sections of ingWAT from Cdkn2aþ/þ and Cdkn2a/ mice fed CD. (I, J) Western blot assay (I) and quantiﬁcation (J)
showing UCP1 protein levels in ingWAT of Cdkn2aþ/þ and Cdkn2a/ mice. Tubulin was used as a loading control. Quantiﬁcation was performed using the ImageJ software. All
values are expressed as means  SEM; *p < 0.05, **p < 0.01, and ***p < 0.001.3.6. CDKN2A modulates adipose tissue browning in human
adipocytes
We next questioned whether deregulated expression of CDKN2A could
be associated to obesity in humans. Interestingly, using global tran-
scriptome proﬁling of adipocytes from lean and obese subjects (GEO:
GSE94752; Ref. [36]) we observed a signiﬁcant increase of CDKN2A
mRNA expression levels in obese insulin-resistant adipocytes
compared to lean controls (Figure 5A). We next wondered whether
decreasing CDKN2A levels in human adipocytes could recapitulate
some of the effects we observed in mice and induce browning in
human cells. Recent reports demonstrated that human-induced
pluripotent stem cells (hiPSCs) could be differentiated into brown/brite
adipose progenitors (hiPSCs-BAP, Refs. [30,31]). To further analyze
whether CDKN2A modulates UCP1 expression in human cells, we
silenced CDKN2A expression during the exponential growth phase of
hiPSCs and differentiated them into brown/brite adipose cells during
22 days as described previously [30,31]. As shown in Figure 5B, C,
p16 and p14 mRNA levels were signiﬁcantly reduced after silencing of
the CDKN2A gene. In addition, UCP1 mRNA levels were strongly
induced in hiPSCs-BAP upon CDKN2A silencing (Figure 5D). This
transcriptional effect was associated with a strong increase of UCP1
protein levels in hiPSCs-BAP CDKN2A-deﬁcient cells (Figure 5E, F).
Moreover, silencing CDKN2A increased lipid droplet accumulation andMOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comadipocyte differentiation in hiPSCs-BAP cells (Figure 5G). Altogether,
our data indicate that CDKN2A is an important mediator of human
adipose tissue browning.
4. DISCUSSION
Our results demonstrate that CDKN2A gene products p16INK4A and
p19ARF are, beside their known role as cell cycle regulatory proteins,
crucial regulators of adipocyte function and adaptation to metabolic
stress. Previous studies have linked the CDKN2A locus to diabetes
pathophysiology through its putative role on pancreatic islet biology
[16,25]. Here, we show that CDKN2A-loss may also impact energy
balance and metabolic homeostasis via non-pancreatic dependent
mechanisms. First, we observed that CDKN2A expression is increased
in human obese adipocytes, and deletion of both p16INK4a and p19ARF
protect mice from diet-induced obesity and associated insulin resis-
tance by enhancing energy expenditure. Second, Cdkn2a invalidation
enhances ingWAT plasticity, facilitating the acquisition of beige adi-
pocytes phenotype. Increasing energy expenditure is associated with
decreased blood glucose and triglycerides and improving hypergly-
cemia and dyslipidemia in both mice and humans [8,46]. In humans,
BAT activation by cold exposure positively affects body weight and
insulin sensitivity [7,47e49]. In addition, the implantation of humann access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 71
Figure 4: Activation of the Protein Kinase A pathway in Cdkn2a/ adipocytes induces white adipose tissue browning. (A) mRNA levels for adipogenic and thermogenic
genes in ingWAT primary differentiated adipocytes isolated from Cdkn2aþ/þ and Cdkn2a/ mice (n ¼ 3). (B) Heatmap showing differences in peptide phosphorylation between
primary differentiated adipocyte from Cdkn2aþ/þ and Cdkn2a/ inguinal fat depots (n ¼ 3). Upstream kinases were identiﬁed using the Human Protein Reference Database. (C)
Pamgene results were analyzed using Ingenuity Pathway Analysis (IPA) to identify the top activated canonical pathways in Cdkn2a/ primary differentiated adipocyte compared
to Cdkn2aþ/þ. (D) PKA activity measurement in tissue homogenates from BAT and ingWAT isolated from Cdkn2aþ/þ and Cdkn2a/ mice (n ¼ 3) treated with DMSO or the
PKA inhibitor H89 at 10 mM. (E, F) Oxygen consumption rate (OCR) was measured using the Seahorse XFe24 platform. After 8 days of differentiation (D8), OCR was measured in
Cdkn2aþ/þ and Cdkn2a/ differentiated adipocytes (E) and quantiﬁcation of basal respiration, basal proton leak (by blocking ATP synthase activity with oligomycin), maximal
respiration by stimulating uncoupling process with FCCP (carbonyl cyanide p-triﬂuoromethoxyphenylhydrazone) and non-mitochondrial respiration (with rotenone) is represented (F,
n ¼ 5). Cdkn2a/ cells were treated 1 h with 10 mM of PKA inhibitor H89 before the experiment (n ¼ 5). All values are expressed as means  SEM; *p < 0.05, **p < 0.01, and
***p < 0.001.
Original Articlebeige adipocytes in mice improves metabolic homeostasis [50].
Interestingly, besides its classical BAT feature, human adult BAT also
has some beige-like characteristics [5,51,52]. Altogether these data
suggest that beige adipocyte activation may be useful against obesity
and related metabolic disorders. In this broad context, our data show
that CDKN2A locus is involved in adipose tissue adaptation to meta-
bolic challenges in mice and humans that may have potential impli-
cations for human obesity.
Although it is not yet clear whether short-term cold acclimation in-
duces browning in humans [7], severe adrenergic stress does activate72 MOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. Thhuman WAT browning [53,54]. In mice, beige adipocytes appear after
cold exposure or other inducers [4]. In our model, we observed the
presence of beige adipocytes in Cdkn2a invalidated mice in the
absence of any browning inducing agent, suggesting that this locus
may act as modulator of the b3-adrenergic receptor (b-AR) that
controls the browning process. The link between b-AR signaling
pathway, CDKN2A and the browning process remains yet to be
elucidated.
Using a multiplex method for global kinase activity proﬁling in ingWAT,
we identiﬁed the PKA pathway among the most signiﬁcantly affectedis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1 e Pathway analysis of RNA-sequencing data in Cdkn2aþ/þ and Cdkn2a/ primary adipocytes.
Upstream
regulator






Target molecules in dataset
CIDEC Other 0.786 6.82E03 ACADL,COX4I2,CYCS,DGAT2,EBF2,FOXC2,PNPLA2,
PPARG,PPARGC1A,PPARGC1B
CCDC3 Other 9.86E03 ACACA,DGAT2,FASN
PPARGC1B 1.230 Transcription regulator 9.86E03 EGLN3,ERO1A,VEGFA
Melatonin Chemical e endogenous mammalian 9.86E03 ACACA,FASN,IRS1
ARNTL 0.518 Transcription regulator 2.18E02 DBP,ELOVL6,PER2,PER3
PTPN1 Phosphatase 1.387 2.62E02 IRS1,IRS2,PPARGC1A,PRDM16,TMEM26
SGCB 0.379 Other 3.31E02 DAG1,SGCD,SGCE
SGCD 1.385 Other 3.31E02 DAG1,SGCB,SGCE
IL1B Cytokine 3.31E02 IRS1,SERPINE1,VEGFA
PNPLA2 0.896 Enzyme 1.131 4.23E02 ACADL,FASN,Gk,PPARG
FFAR4 G-protein coupled receptor 4.60E02 INSR,IRS1
TNFRSF1B 0.504 Transmembrane receptor 4.60E02 SERPINE1,SOCS3
STAT1 Transcription regulator 4.60E02 PPARG,SOCS3
EGR1 Transcription regulator 4.60E02 CSF1,F3
TGFB1 Growth factor 4.60E02 F3,SERPINE1
TNFRSF1A Transmembrane receptor 4.60E02 SERPINE1,SOCS3
Norepinephrine Chemical e endogenous mammalian 1.930 2.03E01 ELOVL6,PPARGC1A,RBP4,SLC2A1,VEGFA
TNF Cytokine Activated 2.048 2.27E01 AOC3,APLN,Celf1,DBI,F3,FABP5,FASN,FOS,INSR,NRIP1,
PPARG,RELA,SERPINE1,SOCS3,TALDO1
NR1H2 0.471 Ligand-dependent nuclear receptor Inhibited 2.449 2.42E01 ELOVL6,FASN,PNPLA2,PRDM16,RB1,Saa3,SLC16A2
PML Transcription regulator Activated 2.000 3.52E01 ACACA,ACOX1,FASN,PPARGC1A
Table 2 e Analysis of upstream transcription factors in RNA-sequencing data from Cdkn2aþ/þ and Cdkn2a/ primary adipocytes.
Molecules in network Score Focus
molecules
Top diseases and functions
CEBPA,FOXC2,ID1,KLF11,MDM2,PPARGC1A,PPARGC1B,PRDM16,RB1,SREBF1,STAT6,TP53 3 9 Cellular Development, Connective Tissue Development and
Function, Tissue Development
ARNTL,DBP,PER2 2 3 Behavior, Nervous System Development and Function,
Organ Morphology
ID3,TCF3 0 1 Hematological System Development and Function,
Lymphoid Tissue Structure and Development, Tissue
Morphology
HDAC3,RELA 0 1 Cell Death and Survival, Neurological Disease, Organismal
Injury and Abnormalitiespathway in Cdkn2a/ adipocytes. Furthermore we demonstrated
that loss of p16INK4a and p19ARF expression is sufﬁcient to activate the
thermogenic program in ingWAT. We also conﬁrmed that PKA activity
was higher in Cdkn2a-deﬁcient ingWAT, suggesting an in vivo acti-
vation of this pathway. Interestingly in the liver, p16INK4A controls
gluconeogenesis and PKA activation in a CDK4-dependent manner
[22]. In contrast in ingWAT, our kinome analysis revealed that CDK4
kinase activity, which is regulated by p16INK4A, is not modulated in the
absence of Cdkn2a. Therefore, the effect on PKA signaling in ingWAT
may be independent of the activation of CDK4. In agreement with this,
the analysis of adipose tissues depots from mice expressing a
constitutively active CDK4 form (CDK4R24C, Ref. [55]) did not show any
signs of browning (data not shown). Moreover, PKA activity is
increased in epididymal WAT from Cdk4-deﬁcient mice [56]. Although
we cannot rule out that other key signaling pathways, including PKG,
could contribute to the phenotype observed in Cdkn2a-deﬁcient mice,
our observations suggest that the molecular mechanisms controlled by
p16INK4A and p19ARF may be tissue-speciﬁc and independent of the
bona ﬁde cell cycle regulation, as previously described in the liver for
other cell cycle regulators [21]. As demonstrated for p16INK4A/CDK4
and p19ARF/mdm2 in the control of cell proliferation or senescence,
respectively, it is tempting to speculate that p16INK4A and p19ARF mayMOLECULAR METABOLISM 8 (2018) 65e76  2017 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comact as direct repressors of the PKA complex to regulate its activity. The
potential interaction of these proteins with different yet speciﬁc part-
ners may subsequently dictate metabolic versus proliferative functions
of p16INK4A and p19ARF.
It is noteworthy that CDKN2A loss-of-function is involved in cancer
development, particularly melanoma [57]. Recent reports shed light on
the contribution of adipose tissue browning process in cancer-
associated cachexia in rodents and humans [58e62]. Here we
describe a novel metabolic function for this key tumor suppressor gene
in energy expenditure and adipose tissue browning. The activation of
the b3-AR pathway during cachexia [63,64], and the putative tight
relationship between CDKN2A and b3-AR, further suggests that
CDKN2A deﬁciency in cancer cells may profoundly affect energy ho-
meostasis facilitating the development of cachexia.
In conclusion, our results demonstrate that the Cdkn2a locus is an
important regulator of energy homeostasis and adipose tissue function
in response to metabolic stress in mice. Mice model approaches can
be useful to elucidate and further carefully dissect the molecular
mechanisms underlying the pleiotropic impact of GWAS on T2D
associated genes. Modulating Cdkn2a-regulated signaling cascades
may constitute novel targetable pathways for treating metabolic
disorders.n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 73
Figure 5: CDKN2A is increased in obese insulin-resistant adipocytes and its silencing in hiPSCs-BAP cells induces UCP1 expression. (A) Correlation between CDKN2A
and human obesity. CDKN2A expression is upregulated in adipocytes from obese insulin-resistant patients. Analyses are based on the human dataset GEO: GSE94752. (BeD
Relative expression of p16 (B), p14 (C), and UCP1 (D) genes in control (siCont) or CDKN2A silenced (siCDKN2A) hiPSCs-BAPs (n ¼ 3). (E, F) Western blot assay (E) and quantiﬁcation
(F) showing UCP1 protein levels in control (siCont) or CDKN2A silenced (siCDKN2A) hiPSCs-BAPs (n ¼ 3). Tubulin was used as a loading control. Quantiﬁcation was performed
using the ImageJ software. (G) Representative microscopy analysis of siCont and siCDKN2A hiPSCs-BAPs after differentiation showing increased lipid droplets upon CDKN2A
silencing. All values are expressed as means  SEM; *p < 0.05 and **p < 0.01.
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